Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma von Eavarone, David A, Al-Alem, Linah, Lugovskoy, Alexey, Prendergast, Jillian M, Nazer, Rawan I, Stein, Jenna N, Dransfield, Daniel T, Behrens, Jeff, Rueda, Bo R

Volltext

Sialyl-Tn serves as a potential therapeutic target for ovarian cancer von Al-Alem, Linah, Prendergast, Jillian M, Clark, Justin, Zarrella, Bianca, Zarrella, Dominique T, Hill, Sarah J, Growdon, Whitfield B, Pooladanda, Venkatesh, Spriggs, David R, Cramer, Daniel, Elias, Kevin M, Nazer, Rawan I, Skates, Steven J, Behrens, Jeff, Dransfield, Daniel T, Rueda, Bo R

Volltext

Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau von Starbuck, Kristen, Al-Alem, Linah, Eavarone, David A, Hernandez, Silvia Fatima, Bellio, Chiara, Prendergast, Jillian M, Stein, Jenna, Dransfield, Daniel T, Zarrella, Bianca, Growdon, Whitfield B, Behrens, Jeff, Foster, Rosemary, Rueda, Bo R

Volltext

Tumor necrosis factor α receptor 1A transduces the inhibitory effect on axon regeneration triggered by IgG anti-ganglioside GD1a antibodies von Báez, Bárbara B., Bacaglio, Cristian R., Prendergast, Jillian M., Rozés-Salvador, Victoria, Sheikh, Kazim A., Bianchet, Mario, Farah, Mohamed H., Schnaar, Ronald L., Bisbal, Mariano, Lopez, Pablo H.H.

Volltext

Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates demonstrate tumor specificity and anti-tumor activity von Prendergast, Jillian M, Galvao da Silva, Ana Paula, Eavarone, David A, Ghaderi, Darius, Zhang, Mai, Brady, Dane, Wicks, Joan, DeSander, Julie, Behrens, Jeff, Rueda, Bo R

Volltext

Production of a mouse monoclonal IgM antibody that targets the carbohydrate Thomsen-nouveau cancer antigen resulting in in vivo and in vitro tumor killing von Trabbic, Kevin R., Kleski, Kristopher A., Shi, Mengchao, Bourgault, Jean-Paul, Prendergast, Jillian M., Dransfield, Daniel T., Andreana, Peter R.

Volltext

Abstract 491: Melanoma patients with multi-Siglec ligands as profiled by HYDRA technology are refractory to PD1 blockade von Petrone, Adam, Frederick, Dennie T., Prendergast, Jillian M., Broderick, James, Normington, Karl, Boland, Genevieve, Peng, Li

Volltext

Abstract 387: Glycoproteomics as a powerful liquid biopsy-based predictor of checkpoint-inhibitor treatment response von Xu, Gege, Rice, Rachel, Huang, Hector, Lindpaintner, Klaus, Prendergast, Jillian M., Normington, Karl, Frederick, Dennie, Boland, Genevieve M., Serie, Daniel

Volltext

Abstract B28: Targeting the tumor-associated carbohydrate antigen STn with humanized anti-Sialyl-Tn monoclonal antibody-drug conjugates inhibits ovarian cancer tumor growth in vitr... von Dransfield, Daniel T., Prendergast, Jillian M., Eavarone, David A., Nazer, Rawan, Al-Alem, Linah, Stein, Jenna, Behrens, Jeff, Rueda, Bo

Volltext

Abstract B114: Humanized anti-Sialyl-Tn monoclonal antibody-drug conjugates inhibit tumor growth in vitro and in vivo von Dransfield, Daniel, Prendergast, Jillian M., Eavarone, David A., Nazer, Rawan, Al-Alem, Linah, Rueda, Bo, Stein, Jenna, Behrens, Jeff

Volltext

Abstract 5625: Myeloid derived suppressor cells (MDSCs) express Sialyl Tn (STn) and are a therapeutic target for anti-STn antibody drug conjugates von Eavarone, David A., Rao, Patricia E., Prendergast, Jillian M., Curtis, Adam D., Zhang, Rong, Shopland, Lindsay S., Stein, Jenna N., Behrens, Jeff, Dransfield, Daniel T.

Volltext

Tumor associated carbohydrate antigens in prostatic adenocarcinoma (PAC): Correlation of sialyl-Tn with malignant phenotype von Kristo, Silva, Brnakova, Zuzana, Goldman, Radoslav, Wei, Renhuizi, Chahine, Joeffrey J, Ko, Kyungmin, Prendergast, Jillian M, Dransfield, Daniel T, Kallakury, Bhaskar

Volltext

Abstract 36: Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates (ADCs) demonstrate tumor specificity in vitro and in vivo antitumor efficacy von Prendergast, Jillian M., Eavarone, David A., Rao, Patricia E., Curtis, Adam D., Shopland, Lindsay S., Hoffert, Todd A., Stein, Jenna, Behrens, Jeff, Dransfield, Daniel T.

Volltext

Glycan-Interacting Compounds and Methods of Use von Eavarone, David A, Dransfield, Daniel T, Prendergast, Jillian M

Volltext bestellen

Glycan-Interacting Compounds and Methods of Use von Eavarone, David A, Behrens, Jeffrey, Prendergast, Jillian M

Volltext bestellen

Compositions and Methods for Treating Cancer von Rao, Patricia, Eavarone, David A, Prendergast, Jillian M

Volltext bestellen

Compositions and Methods for Targeting Cancer Stem Cells von Rueda, Bo R, Eavarone, David A, Behrens, Jeffrey, Starbuck, Kristen D, Foster, Rosemary, Prendergast, Jillian M

Volltext bestellen

Glycan-Interacting Compounds and Methods of Use von Eavarone, David A, Dransfield, Daniel T, Prendergast, Jillian M

Volltext bestellen

GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE von DANIEL T DRANSFIELD, DAVID A EAVARONE, JILLIAN M PRENDERGAST

Volltext bestellen

Glycan-Interacting Compounds and Methods of Use von Eavarone, David A, Behrens, Jeffrey, Prendergast, Jillian M

Volltext bestellen